HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $423,541 | +5.2% | 3,661 | -6.5% | 0.00% | +50.0% |
Q2 2023 | $402,555 | +14.6% | 3,914 | +21.6% | 0.00% | 0.0% |
Q1 2023 | $351,322 | -6.8% | 3,219 | -2.8% | 0.00% | -33.3% |
Q4 2022 | $376,906 | +77.0% | 3,312 | -3.6% | 0.00% | +50.0% |
Q3 2022 | $213,000 | -22.0% | 3,437 | +0.4% | 0.00% | 0.0% |
Q2 2022 | $273,000 | -1.4% | 3,425 | +30.1% | 0.00% | 0.0% |
Q1 2022 | $277,000 | -4.2% | 2,632 | -1.9% | 0.00% | +100.0% |
Q4 2021 | $289,000 | -4.9% | 2,682 | -3.5% | 0.00% | -50.0% |
Q3 2021 | $304,000 | +5.2% | 2,779 | -9.8% | 0.00% | +100.0% |
Q2 2021 | $289,000 | -25.7% | 3,081 | -27.1% | 0.00% | 0.0% |
Q1 2021 | $389,000 | +12.8% | 4,224 | -10.6% | 0.00% | 0.0% |
Q4 2020 | $345,000 | -9.7% | 4,723 | -3.9% | 0.00% | -50.0% |
Q3 2020 | $382,000 | +42.0% | 4,913 | +1.7% | 0.00% | +100.0% |
Q2 2020 | $269,000 | +186.2% | 4,831 | +52.6% | 0.00% | 0.0% |
Q1 2020 | $94,000 | -14.5% | 3,165 | +4.0% | 0.00% | – |
Q4 2019 | $110,000 | +27.9% | 3,042 | -3.4% | 0.00% | – |
Q3 2019 | $86,000 | +13.2% | 3,148 | 0.0% | 0.00% | – |
Q2 2019 | $76,000 | – | 3,148 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |